comparemela.com

Latest Breaking News On - தலை ஆஃப் தகவல் தொழில்நுட்பம் - Page 1 : comparemela.com

Angaza Awards unveils the Top 10 women to watch in banking and finance

Shares The Angaza Awards; Women to Watch in Banking and Finance program has unveiled its list of Top 10 women who are steering and shaping the financial services sector. The list was compiled after a four-month entry period which saw professionals from Kenya, Rwanda, South Sudan, Tanzania and Uganda submit applications. The Kenyan Wallstreet, a financial news media company partnered with Kaleidoscope Consultants in an effort to raise awareness of seasoned women who are shaping and influencing the sector through their organizations. The Angaza Award criteria included an assessment of the applicants’ area of responsibility and contribution to firm performance. Professionals in Banking, Capital Markets, Insurance, Investment Banking, Fintech, Fund Management, Microfinance, and SACCOs were invited to submit their applications or nominations via the Kenyan Wallstreet Award Web page.

Lina Higiro among top 3 seasoned women shaping East Africa's banking, financial sector > IGIHE

Lina Higiro among top 3 seasoned women shaping East Africa's banking, financial sector > IGIHE
igihe.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from igihe.com Daily Mail and Mail on Sunday newspapers.

Cellectis Provides Business Update and Reports 4th Quarter and Full Year 2020 Financial Results

Cellectis Provides Business Update and Reports 4th Quarter and Full Year 2020 Financial Results March 04, 2021 16:42 ET | Source: Cellectis Inc. Cellectis Inc. New York, New York, UNITED STATES Enrollment ongoing in 3 Cellectis-sponsored Phase 1 dose-escalation trials BALLI-01 in r/r B-ALL patients, AMELI-01 in r/r AML patients and MELANI-01 in r/r MM patients in 7 leading US clinical centers Preliminary results from our Phase 1 BALLI-01 clinical study of UCART22 in adults with r/r B-ALL presented in oral session at 2020 ASH Annual Meeting Partner Allogene Therapeutics presented initial results from Phase 1 ALPHA clinical study of licensed ALLO-501 in r/r NHL at 2020 ASCO Annual Meeting and from Phase 1 UNIVERSAL clinical study of licensed ALLO-715 in r/r MM at 2020 ASH Annual Meeting

Миллиеналы лучше приспособлены к выживанию, чем работяги 90-х

Миллиеналы лучше приспособлены к выживанию, чем работяги 90-х
vsesmi.ru - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from vsesmi.ru Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.